Search for: "Agilent Technologies Inc., v. Affymetrix, Inc."
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
4 Jun 2009, 9:56 pm
Unlike the situation where the written description requirement is used to invalidate patents (which is the subject of a petition for en banc review in Ariad v. [read post]
2 Jul 2009, 11:42 am
Agilent Techs., Inc. v. [read post]
28 Apr 2010, 9:55 pm
Patent and Trademark Office cancelled Rule 41.200(b) as a result of the decision rendered in Agilent Technologies, Inc. v. [read post]
22 Apr 2012, 8:39 pm
Agilent Technologies Inc. 1:12-cv-00434; filed April 6, 2012 in the District Court of Delaware Enzo Life Sciences Inc. v. [read post]
8 Jun 2009, 12:37 am
Agilent Technologies v. [read post]
15 Apr 2010, 5:33 am
In Agilent Technologies, Inc. v. [read post]
29 Oct 2010, 3:10 am
(here), the Federal Circuit applied a non-traditional test in its interference-in-fact analysis, and in Agilent Technologies Inc. v. [read post]
17 Apr 2011, 11:03 pm
Affymetrix, Inc. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi… [read post]
